Innovative Medicines Initiative phase 2 (IMI2)
The Innovative Medicines Initiative (IMI) is Europe’s biggest public-private partnership, jointly undertaken by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The goal of the IMI public-private partnership is to facilitate collaboration between key players in healthcare research including, but not limited to, patient organizations, universities and pharmaceuticals, and thereby [...]
